210 related articles for article (PubMed ID: 31376677)
1. The Yin and Yang of myelodysplastic syndromes and autoimmunity: The paradox of autoimmune disorders responding to therapies specific for MDS.
Fozza C; La Nasa G; Caocci G
Crit Rev Oncol Hematol; 2019 Oct; 142():51-57. PubMed ID: 31376677
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune disorders associated with myelodysplastic syndromes: clinical, prognostic and therapeutic implications.
Fozza C; Murtas A; Caocci G; La Nasa G
Leuk Res; 2022 Jun; 117():106856. PubMed ID: 35525186
[TBL] [Abstract][Full Text] [Related]
3. The burden of autoimmunity in myelodysplastic syndromes.
Fozza C
Hematol Oncol; 2018 Feb; 36(1):15-23. PubMed ID: 28449370
[TBL] [Abstract][Full Text] [Related]
4. Immune alterations in untreated and treated myelodysplastic syndrome.
Mewawalla P; Dasanu CA
Expert Opin Drug Saf; 2011 May; 10(3):351-61. PubMed ID: 21417834
[TBL] [Abstract][Full Text] [Related]
5. [Myelodysplastic syndromes and autoimmunity].
Stalder G; Alberio L; Ribi C
Rev Med Suisse; 2015 Apr; 11(469):820-2, 824-5. PubMed ID: 26040163
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune phenomena in patients with myelodysplastic syndromes.
Enright H; Miller W
Leuk Lymphoma; 1997 Feb; 24(5-6):483-9. PubMed ID: 9086438
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
Saif MW; Hopkins JL; Gore SD
Leuk Lymphoma; 2002 Nov; 43(11):2083-92. PubMed ID: 12533032
[TBL] [Abstract][Full Text] [Related]
8. The immune landscape of myelodysplastic syndromes.
Fozza C; Crobu V; Isoni MA; Dore F
Crit Rev Oncol Hematol; 2016 Nov; 107():90-99. PubMed ID: 27823655
[TBL] [Abstract][Full Text] [Related]
9. Myelodysplastic Syndromes (MDS) and autoimmune disorders (AD): cause or consequence?
Braun T; Fenaux P
Best Pract Res Clin Haematol; 2013 Dec; 26(4):327-36. PubMed ID: 24507810
[TBL] [Abstract][Full Text] [Related]
10. Myelodysplasia and autoimmunity.
Giannouli S; Kanellopoulou T; Voulgarelis M
Curr Opin Rheumatol; 2012 Jan; 24(1):97-102. PubMed ID: 22157417
[TBL] [Abstract][Full Text] [Related]
11. Retuning the immune system in myelodysplastic syndromes: from immunomodulatory approaches to vaccination strategies and non myeloablative hemopoietic cell transplant.
Fozza C
Crit Rev Oncol Hematol; 2019 Jan; 133():112-119. PubMed ID: 30661647
[TBL] [Abstract][Full Text] [Related]
12. The yin-yang of immunity: Immune dysregulation in myelodysplastic syndrome with different risk stratification.
Peng X; Zhu X; Di T; Tang F; Guo X; Liu Y; Bai J; Li Y; Li L; Zhang L
Front Immunol; 2022; 13():994053. PubMed ID: 36211357
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy.
Enright H; Jacob HS; Vercellotti G; Howe R; Belzer M; Miller W
Br J Haematol; 1995 Oct; 91(2):403-8. PubMed ID: 8547082
[TBL] [Abstract][Full Text] [Related]
14. Immune Mechanisms in Myelodysplastic Syndrome.
Glenthøj A; Ørskov AD; Hansen JW; Hadrup SR; O'Connell C; Grønbæk K
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27314337
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune manifestations associated with myelodysplastic syndromes.
Grignano E; Jachiet V; Fenaux P; Ades L; Fain O; Mekinian A
Ann Hematol; 2018 Nov; 97(11):2015-2023. PubMed ID: 30091023
[TBL] [Abstract][Full Text] [Related]
16. Myelodysplastic syndrome associated with multiple autoimmune disorders.
Farmakis D; Polymeropoulos E; Polonifi A; Deftereos S; Giakoumi X; Floudas H; Grapsa A; Aessopos A
Clin Rheumatol; 2005 Aug; 24(4):428-30. PubMed ID: 15827686
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive review of myelodysplastic syndrome patients with autoimmune diseases.
Giannouli S; Voulgarelis M
Expert Rev Clin Immunol; 2014 Dec; 10(12):1679-88. PubMed ID: 25308147
[TBL] [Abstract][Full Text] [Related]
18. Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy.
Aggarwal S; van de Loosdrecht AA; Alhan C; Ossenkoppele GJ; Westers TM; Bontkes HJ
Br J Haematol; 2011 Jun; 153(5):568-81. PubMed ID: 21488861
[TBL] [Abstract][Full Text] [Related]
19. Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts.
Voulgarelis M; Giannouli S; Ritis K; Tzioufas AG
Eur J Clin Invest; 2004 Oct; 34(10):690-700. PubMed ID: 15473894
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells in myelodysplastic syndromes: from pathogenesis to immunotherapy.
Kerkhoff N; Bontkes HJ; Westers TM; de Gruijl TD; Kordasti S; van de Loosdrecht AA
Immunotherapy; 2013 Jun; 5(6):621-37. PubMed ID: 23725285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
